Business Context and Reporting Period
This Form 8-K Current Report was filed by Core Scientific, Inc. on May 26, 2026. The filing reports a corporate governance event: the appointment of a new independent director to the Board of Directors and the Nominating and Corporate Governance Committee.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statement data.
Material Changes
The primary material change reported is the addition of Steve M. Smith to the Board of Directors, effective immediately on May 26, 2026. Mr. Smith brings significant industry experience, having served as CEO of Zayo since 2020 and previously as CEO and President of Equinix from 2007 to 2018. The Board has determined Mr. Smith meets the independence requirements of the Sarbanes-Oxley Act and Nasdaq listing standards.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management outlook, or specific risk factors. It notes that Mr. Smith will receive cash and equity compensation commensurate with other non-employee directors. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the independence status of the newly appointed director, Steve M. Smith, against Nasdaq listing standards.
- Review the specific terms of the cash and equity compensation package for Mr. Smith's board service.
- Confirm the absence of any undisclosed related party transactions involving Mr. Smith.
- Check subsequent filings for any strategic shifts in data center operations or network infrastructure resulting from the new board composition.